Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)

BACKGROUND: Many patients with brain metastases from non-small cell lung cancer have limited survival, while others survive for several years, depending on patterns of spread, EGFR and ALK alterations, among others. The purpose of this study was to validate a new prognostic model (Lung-molGPA) origi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Hintz, Mandy, Oehlke, Oliver, Bilger, Angelika, Grosu, Anca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483956/
https://www.ncbi.nlm.nih.gov/pubmed/28651600
http://dx.doi.org/10.1186/s13014-017-0844-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483956/
https://www.ncbi.nlm.nih.gov/pubmed/28651600
http://dx.doi.org/10.1186/s13014-017-0844-6

Ejemplares similares